Ibere Pharmaceuticals
Ibere Pharmaceuticals (IBER) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
iber · pe ratio · data through Dec 31, 2021
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Ibere Pharmaceuticals (IBER) measures how much investors pay for each dollar of the company's trailing earnings. IBER's current PE ratio of 74.91x is calculated by dividing its stock price of $10.18 by its TTM earnings per share of $0.14. +4.7% elevated vs 5Y avg 71.5x
Source: FMP · /ratios-ttm · /analyst-estimates · 2021-12-31
PE Ratio History
2020 – 2021 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Ibere PharmaceuticalsYou IBER | $176M | 74.91x | +67.2% | $0.14 |
 AP Acquisition Corp. APCA | $179M | 64.76x | +44.6% | $0.17 |
 Bridgetown Holdings Limited BTWN | $184M | N/A | — | — |
 Fusion Acquisition Corp. II FSNB | $178M | N/A | — | — |
 Learn CW Investment Corporation LCW | $164M | 79.77x | +78.1% | $0.14 |
 Enphys Acquisition Corp. NFYS | $164M | 28.29x | -36.8% | $0.38 |
 Parabellum Acquisition Corp. PRBM | $179M | 6.37x | -85.8% | $1.53 |
Industry Average 4 peers with valid PE | — | 44.80x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2021-12-31Latest FY2021 | 71.52x | $0.14 | — | |
2020-12-31 FY2020 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Ibere Pharmaceuticals (IBER) measures how much investors pay for each dollar of the company's trailing earnings. IBER's current PE ratio of 74.91x is calculated by dividing its stock price of $10.18 by its TTM earnings per share of $0.14.
Frequently asked questions
IBER pe ratio · 6 questionsIBER's current PE ratio is 74.91x as of 2026-06-09, based on a stock price of $10.18 and TTM EPS of $0.14. Data sourced from Financial Modeling Prep via IBER's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Ibere Pharmaceuticals SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09